Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein, CF

Name: Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein, CF
Brand: R&D Systems
SKU: 10668-CV

R&D Systems, Inc. a Bio-Techne Brand

Catalog # 10668-CV

Product Datasheet / COA / SDS

Catalog #

Availability

Size / Price

Qty

Setting the standard in quality research reagents

Key Product Details

Source:	CHO
Accession #:	YP_009724395.1

View Full Technical Details for Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein, CF

Product Specifications for Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein, CF

Source

Chinese Hamster Ovary cell line, CHO-derived sars-cov-2 ORF7a protein

SARS-CoV-2 ORF7a (Glu16-Leu96) Accession # YP_009724395.1	IEGRMD	Human IgG₁ (Pro100-Lys330)
N-terminus		C-terminus

Purity

>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal sequence Analysis

Glu16

Predicted Molecular Mass

36 kDa

SDS-PAGE

37-42 kDa, under reducing conditions.

Scientific Data Examples for Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein, CF

	Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein SDS-PAGE. 2 μg/lane of Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein (Catalog # 10668-CV) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 37-42 kDa.

Formulation, Preparation and Storage

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

10668-CV

Formulation	Supplied as a 0.2 μm filtered solution in Tris, NaCl, TCEP and Glycerol.
Shipping	The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 3 months, -20 to -70 °C under sterile conditions after opening.

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Background: ORF7a

Open Reading Frame 7a (ORF7a) is one of eight accessory proteins encoded at the 3' region of the coronavirus (CoV) genome (1). The accessory proteins are largely dispensable for viral replication and growth in vitro (2,3). Although not essential for replication the accessory proteins are thought to modulate virus-host interactions that are important during infection (4). Coronaviruses include various highly pathogenic strains such as SARS-CoV, MERS-CoV and SARS-CoV2 that have had significant impact on humans as well as strains that have negatively impacted livestock. ORF7a from SARS-CoV2 is a small 121 amino acid (aa) type I transmembrane protein (5,6). ORF7a contains an N-terminal signal peptide, a luminal domain, transmembrane domain, and a short C-terminal cytoplasmic tail that functions as an ER export signal (5,7). It is expressed and retained intracellularly in cells infected with SARS-CoV and primarily localized to the Golgi (5,7) Although the function of the accessory proteins has not been well-defined, ORF7a has been shown to activate p38 MAPK(7), NF-kB, and JNK signaling pathways, enhance production of inflammatory chemokines known to be upregulated in SARS-CoV infection (8), and inhibit cellular protein synthesis (9). These reports indicate ORF7a may be involved in the inflammatory response and induction of apoptosis of SARS-CoV infected cells (7-10). ORF7a has also been reported to bind and prevent glycosylation of host cell protein bone marrow stromal antigen 2 (BST-2). Binding inhibits BST-2's ability to block the release of SARS-CoV virions (11). Therapeutics designed to inhibit the interaction of the ectodomain of ORF7a and BST2 have been proposed as a method to inhibit virus growth (11).

Item	Value
References	Hartenian, E. et al. (2020) J. Biol. Chem. 295:12910. Haijema, B.J. et al. (2004) J. Virol. 78:3863. Yount, B. et al. (2005) J. Virol. 79:14909. Liu, D.X. et al. (2014) Antiviral Res. 109:97. Nelson, C.A. et al. (2005) Structure 13:75. Yoshimoto, F.K. et al. (2020) Protein J. 39:198. Schaecher, S.R. et al. (2007) J. Virol. 81:11054. Kanzawa, N. et al. (2006) FEBS Lett. 580:6807. Kopecky-Bromberg, S.A. et al. (2006) J. Virol. 80:785. Tan, Y. et al. (2004) J. Virol. 78:14043. Taylor, J.K. et al. (2015) J. Virol. 89:11820.
Long Name	ORF7a
Entrez Gene IDs	43740573 (SARS-CoV-2)
Alternate Names	ORF7a

Citations for Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein, CF

Please visit our Instrument Citation Database to search our collection of scientific articles that feature our instruments.

Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein, CF

R&D Systems, Inc. a Bio-Techne Brand

Key Product Details

Customers also Viewed

Product Specifications for Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein, CF

Scientific Data Examples for Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein, CF

Formulation, Preparation and Storage

Carrier Free

Reconstitution Calculator

Background: ORF7a

Citations for Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein, CF

Product Documents for Recombinant SARS-CoV-2 ORF7a Fc Chimera Protein, CF

Product Datasheets

COA

Certificate of Analysis

SDS

Bio-Techne Brands

Stay Connected